Objective
The project concerns the development of innovative methodologies for the synthesis of novel bioactive natural products (meroterpenoids) and their potential application for the discovery of new medicines to treat resistant cancers and resistant microbial infections. The fundamentals of its originality and innovation are:
a) The synthesis of a focused library of novel bioactive meroterpenoids, planned to have an impact in the fields of anticancer and anti-infective medicinal chemistry.
b) The application of a flexible and concise dual biomimetic synthetic strategy, which will significantly impact the field of natural products synthesis focused on drug discovery.
c) An extensive use of novel methods for polyene cyclisation including processes based on sulfite, sulfate, phosphate and other electrophilic initiators including radical cations generated by photoredox catalysis, coupled with polyketide aromatisation, will greatly impact in the field of cyclisation cascades in general as well as meroterpenoids synthesis.
Dr Fabbrizzi is an experienced experimental scientist with substantial academic and industrial experience whose research career was interrupted in October 2015 due to funding crises in Italy. The award of a H2020 fellowship, if this proposal is successful, will be critical in supporting the resumption of his independent research career. Working in the supportive environment of Imperial College under the expert guidance of professor Barrett he will considerably reinforce his knowledge of natural product synthesis and drug discovery and will resume his position in the European research community improving his profile to face the current challenges of organic and medicinal chemistry.
keywords/descriptors: Synthetic organic chemistry, Natural product synthesis, Medicinal chemistry
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- natural sciences chemical sciences organic chemistry
- medical and health sciences basic medicine medicinal chemistry
- medical and health sciences clinical medicine oncology
- natural sciences chemical sciences catalysis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-CAR - CAR – Career Restart panel
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
SW7 2AZ London
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.